Meta-analysis demonstrates that treatment effect on total GFR slope strongly predicts clinical endpoints. Study findings presented at the European Renal Association 2023 congress in Milan, Italy, ...
Credit: Shutterstock Accurate assessment of glomerular filtration rate in patients with cancer is crucial to determine drug eligibility and dosing, while balancing the risks for undertreatment and ...
Patients with chronic kidney disease (CKD) stages 3b or 4 experienced slower decline in estimated glomerular filtration rate 20 months after enrollment in a value-based kidney care program. Objectives ...
A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk ...
The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of ...
HOUSTON — The benefits of SGLT2 inhibitors in slowing kidney disease progression are similar regardless of patients’ type 2 diabetes (T2D) or albuminuria status, the results of a recent meta-analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results